Posted by linkadge on September 24, 2008, at 21:54:57
In reply to Re: Circadin - Lundbeck launches new melatnonin tablet » Quintal, posted by Bob on September 24, 2008, at 20:59:59
The efficacy voldoxan is more than its melatonin receptor agonism. It is a 5-ht2b/c antagonist. This may confer antidepressant anxiolytic effects.
Linkadge
poster:linkadge
thread:853852
URL: http://www.dr-bob.org/babble/20080915/msgs/853902.html